What question did this study set out to answer?

To evaluate the impact of the Oncology Care Model on the utilization of supportive care medications during cancer chemotherapy.

February 25, 2022Journal of Clinical Oncology

Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment

View Full Paper

Ask AI

Bookmark

Authors

GBGabriel A. BrooksDartmouth College MLMary Beth LandrumHarvard University NKNirav S. KapadiaDartmouth College

Discussion

Member takes

Implication

Cohort study reveals reduced use of high-cost supportive care drugs in Medicare beneficiaries undergoing chemotherapy, indicating more value-conscious cancer care.

Key Points

To evaluate the impact of the Oncology Care Model on the utilization of supportive care medications during cancer chemotherapy.
Analyzed Medicare claims data from 2013 to 2019 evaluating chemotherapy episodes across 201 Oncology Care Model practices and 534 comparison practices.
Assessed utilization of denosumab, prophylactic white blood cell growth factors, neurokinin-1 antagonists, and long-acting serotonin antagonists using difference-in-differences models.
OCM implementation was associated with a 5.0 percentage point relative reduction in denosumab use for breast cancer bone metastases (90% CI, -7.1 to -2.8).
Prophylactic white blood cell growth factor use decreased by 7.6 percentage points in breast cancer chemotherapy with intermediate febrile neutropenia risk (90% CI, -12.6 to -2.7), but showed no change in high- or low-risk regimens.
Prophylactic neurokinin-1 antagonist use during high emetic risk chemotherapy decreased by 6.0 percentage points (90% CI, -9.0 to -3.1), with concurrent declines observed for long-acting serotonin antagonists.

Cite This Study

Brooks et al. (2022) studied this question.

synapsesocial.com/papers/6a894f8bb1e5d05ea8ec69b7 https://doi.org/10.1200/jco.21.02342

View Full Paper

Ask AI

Bookmark

Implication

Cohort study reveals reduced use of high-cost supportive care drugs in Medicare beneficiaries undergoing chemotherapy, indicating more value-conscious cancer care.

Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider